OSR Health CEO says two subsidiaries draw out-licensing interest as Nasdaq bid deadline nears

Reuters2026/08/11 12:52

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

OSR Holdings’ CEO said Nasdaq is expected to decide on continued listing by Aug. 18 if shares fail to close at $1.
Two subsidiaries received inbound out-licensing inquiries; one reached preliminary term-sheet talks, the other remains early-stage.
CEO said he has not bought more shares because he is already the largest investor and has funded multiple rounds to support R&D.
Management said it is working to preserve the Nasdaq listing organically while subsidiary business development accelerates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608110852ACCESSWRNAPR_____1206049) on August 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

OSR Health CEO says two subsidiaries draw out-licensing interest as Nasdaq bid deadline nears

You may also like

Crypto prices